These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34461175)

  • 21. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
    Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
    BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.
    Yang SP; Chen YY; Hsu HS; Wang FD; Chen LY; Fung CP
    BMC Infect Dis; 2013 Jan; 13():10. PubMed ID: 23298156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare associated infections in Paediatric Intensive Care Unit of a tertiary care hospital in India: Hospital stay & extra costs.
    Sodhi J; Satpathy S; Sharma DK; Lodha R; Kapil A; Wadhwa N; Gupta SK
    Indian J Med Res; 2016 Apr; 143(4):502-6. PubMed ID: 27377508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the costs of hospital-acquired infections in New Zealand.
    Graves N; Nicholls TM; Morris AJ
    Infect Control Hosp Epidemiol; 2003 Mar; 24(3):214-23. PubMed ID: 12683515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable.
    Schmier JK; Hulme-Lowe CK; Semenova S; Klenk JA; DeLeo PC; Sedlak R; Carlson PA
    Clinicoecon Outcomes Res; 2016; 8():197-205. PubMed ID: 27257390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and economic burden of healthcare-associated infections: A prospective cohort study.
    Gidey K; Gidey MT; Hailu BY; Gebreamlak ZB; Niriayo YL
    PLoS One; 2023; 18(2):e0282141. PubMed ID: 36821590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India.
    Kumar S; Sen P; Gaind R; Verma PK; Gupta P; Suri PR; Nagpal S; Rai AK
    Am J Infect Control; 2018 Feb; 46(2):202-206. PubMed ID: 29046215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China.
    Liu X; Cui D; Li H; Wang Q; Mao Z; Fang L; Ren N; Sun J
    J Hosp Infect; 2020 Jun; 105(2):295-305. PubMed ID: 31931043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health care-associated infections in pre-transplant liver intensive care unit: Perspectives and challenges.
    Hassan EA; Elsherbiny NM; Abd El-Rehim AS; Soliman AMA; Ahmed AO
    J Infect Public Health; 2018; 11(3):398-404. PubMed ID: 28965794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Device-associated infections rates in adult, pediatric, and neonatal intensive care units of hospitals in the Philippines: International Nosocomial Infection Control Consortium (INICC) findings.
    Navoa-Ng JA; Berba R; Galapia YA; Rosenthal VD; Villanueva VD; Tolentino MC; Genuino GA; Consunji RJ; Mantaring JB
    Am J Infect Control; 2011 Sep; 39(7):548-54. PubMed ID: 21616564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Device-associated nosocomial infection in general hospitals, Kingdom of Saudi Arabia, 2013-2016.
    Gaid E; Assiri A; McNabb S; Banjar W
    J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S35-S40. PubMed ID: 29801591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Device-associated infection rates and extra length of stay in an intensive care unit of a university hospital in Wroclaw, Poland: International Nosocomial Infection Control Consortium's (INICC) findings.
    Kübler A; Duszynska W; Rosenthal VD; Fleischer M; Kaiser T; Szewczyk E; Barteczko-Grajek B
    J Crit Care; 2012 Feb; 27(1):105.e5-10. PubMed ID: 21737244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
    Vrijens F; Hulstaert F; Devriese S; van de Sande S
    Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals.
    Cai Y; Hoo GSR; Lee W; Tan BH; Yoong J; Teo YY; Graves N; Lye D; Kwa AL
    PLOS Glob Public Health; 2022; 2(12):e0001311. PubMed ID: 36962882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.
    Zimlichman E; Henderson D; Tamir O; Franz C; Song P; Yamin CK; Keohane C; Denham CR; Bates DW
    JAMA Intern Med; 2013 Dec 9-23; 173(22):2039-46. PubMed ID: 23999949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic and health impact modelling of a whole genome sequencing-led intervention strategy for bacterial healthcare-associated infections for England and for the USA.
    Fox JM; Saunders NJ; Jerwood SH
    Microb Genom; 2023 Aug; 9(8):. PubMed ID: 37555752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence surveys of nosocomial infections using a random sampling method in Marseille hospitals.
    Sartor C; Sambuc R; Bimar MC; Gulian C; De Micco P
    J Hosp Infect; 1995 Mar; 29(3):209-16. PubMed ID: 7615938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare-Associated Infections in Cardiac Surgery Patients With Prolonged Intensive Care Unit Stay.
    Mazzeffi M; Gammie J; Taylor B; Cardillo S; Haldane-Lutterodt N; Amoroso A; Harris A; Thom K
    Ann Thorac Surg; 2017 Apr; 103(4):1165-1170. PubMed ID: 28267981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-level cost analysis of intensive care unit acquired infections: A prospective cohort study.
    Bezerra IL; Nassar Junior AP; Dos Santos TM; Tomazini BM; Veiga VC; Arns B; Nascimento GM; Cavalcanti AB; Malheiro DT; Pereira AJ;
    J Hosp Infect; 2024 Jul; ():. PubMed ID: 39032569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece.
    Kritsotakis EI; Kontopidou F; Astrinaki E; Roumbelaki M; Ioannidou E; Gikas A
    Infect Drug Resist; 2017; 10():317-328. PubMed ID: 29066921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.